Book a demo
Presence & RecognitionEvent: September 7, 2026

GBA Group Pharma is hosting the third webinar on Nitrosamines in September 2026, featuring a live interactive Q&A session on risk assessment, analytical control, and regulatory context.

Published

Signal category

Presence & Recognition

Quote

In September 2026, our experts will return for the third GBA Group Pharma webinar on Nitrosamines, focusing on three core areas

GBA Group Pharma team

Company

Industry
Public Health
Location
Hamburg, DE
Company size
128 employees

GBA Group Pharma - association of experts for research, development and quality assurance in the fields of pharmaceuticals, biotech, agrochemicals and cosmetics. GBA Group Pharma combines expertise from research, development and quality assurance for a wide range of issues in the fields of pharmaceuticals, biotechnology and agrochemicals. The international network of scientists, experienced project managers and highly qualified laboratory experts offers skilled support in all areas of the research, development and product life cycle. Our precise and quality-conscious service portfolio includes a wide range of services that companies need in order to concentrate optimally on their core business. That is why we advise and accompany them internationally with local contacts on site, from the analysis to the market launch with a high level of innovative strength, passion and the endeavor to provide the best services. With their growing demands in the wide-ranging field of research and development, we have a growing incentive to continuously develop further. The safety of your products is just as much our focus as serving society for safer and better healthcare - we are GBA Group Pharma.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.